Evidence map›Paper›PMID 26260220›Full record

ArticleMayo Clinic proceedings2015

Uric Acid: A Missing Link Between Hypertensive Pregnancy Disorders and Future Cardiovascular Disease?

Tracey L Weissgerber, Natasa M Milic, Stephen T Turner, Reem A Asad, Thomas H Mosley, Sharon L R Kardia, Craig L Hanis, Vesna D Garovic

Open access · greenAbstract read
In one paragraph

Article in Mayo Clinic proceedings, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Uric acid participating in female reproductive disorders: a review.Reproductive biology and endocrinology : RB&E · 2021
    Review
  4. Development and validation of a nomogram for the early prediction of preeclampsia in pregnant Chinese women.Hypertension research : official journal of the Japanese Society of Hypertension · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 3 countries.

Tracey L WeissgerberDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN. Electronic address: weissgerber.tracey@mayo.edu.
Natasa M MilicDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN; Medical Faculty, Department of Biostatistics, University of Belgrade, Belgrade, Serbia.
Stephen T TurnerDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Reem A AsadDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN; Al Adan Hospital, Ministry of Health, Kuwait.
Thomas H MosleyUniversity of Mississippi Medical Center, Jackson.
Sharon L R KardiaDepartment of Epidemiology, University of Michigan, Ann Arbor.
Craig L HanisHuman Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston.
Vesna D GarovicDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Mayo Clinic · USAdan Hospital · KWThe University of Texas Health Science Center at Houston · USUniversity of Belgrade · RSUniversity of Michigan–Ann Arbor · USUniversity of Mississippi Medical Center · US

Funding

Mayo Clinic Center for Translational Science ActivitiesUL1TR000135 · NCATS · MAYO CLINIC ROCHESTER · PI KHOSLA, SUNDEEP · 2012 to 2015
$41.2M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
The Family Blood Pressure Program (HyperGEN Network)U01HL054471 · NHLBI · UNIVERSITY OF UTAH · PI HUNT, STEVEN C. · 2000 to 2007
$7.4M
Mayo Clinic Interdisciplinary Women's Health Research ProgramK12HD065987 · NICHD · MAYO CLINIC ROCHESTER · PI KANTARCI, KEJAL · 2010 to 2023
$6.7M
The Family Blood Pressure Program (GENOA Network)U01HL054481 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI BOERWINKLE, ERIC A · 2000 to 2007
$6.7M
Sex-specific Risk for Vascular Dysfunction and Cognitive DeclineP50AG044170 · NIA · MAYO CLINIC ROCHESTER · PI MILLER, VIRGINIA M · 2012 to 2017
$6.1M
The Family Blood Pressure Program (SAPPHIRe Network)U01HL054498 · NHLBI · UNIVERSITY OF HAWAII AT MANOA · PI CURB, JESS DAVID · 1995 to 2007
$5.9M
GENETIC DETERMINANTS OF HIGH BLOOD PRESSUREU01HL054512 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEDER, ALAN B · 2000 to 2007
$5.8M
NCATS NIH HHS UL1 TR000135NHLBI NIH HHS U01 HL054471NHLBI NIH HHS U01HL054471NHLBI NIH HHS U01 HL054481NHLBI NIH HHS U01HL054481NHLBI NIH HHS U01 HL054498NHLBI NIH HHS U01HL054498NHLBI NIH HHS U01 HL054512NHLBI NIH HHS U01HL054512NIA NIH HHS P50 AG044170NIA NIH HHS P-50 AG44170NIA NIH HHS R01 AG034676NICHD NIH HHS K12 HD065987NICHD NIH HHS K12HD065987
6 · The paper itself

Abstract

objectiveTo determine whether women who had a hypertensive pregnancy disorder (HPD) have elevated uric acid concentrations decades after pregnancy as compared with women who had normotensive pregnancies. PATIENTS AND

methodsThe Genetic Epidemiology Network of Arteriopathy study measured uric acid concentrations in Hispanic (30%), non-Hispanic white (28%), and non-Hispanic black (42%) women (mean age, 60 ± 10 years). This cross-sectional study was conducted between July 1, 2000, and December 31, 2004. Hispanic participants were recruited from families with high rates of diabetes, whereas non-Hispanic participants were recruited from families with high rates of hypertension. This analysis compared uric acid concentrations in women with a history of normotensive (n = 1846) or hypertensive (n = 408) pregnancies by logistic regression.

resultsWomen who had an HPD had higher uric acid concentrations (median, 5.7 mg/dL vs 5.3 mg/dL; P < .001) and were more likely to have uric acid concentrations above 5.5 mg/dL (54.4% vs 42.4%; P = .001) than were women who had normotensive pregnancies. These differences persisted after adjusting for traditional cardiovascular risk factors, comorbidities, and other factors that affect uric acid concentrations. A family-based subgroup analysis comparing uric acid concentrations in women who had an HPD (n = 308) and their parous sisters who had normotensive pregnancies (n = 250) gave similar results (median uric acid concentrations, 5.7 mg/dL vs 5.2 mg/dL, P = 0.02; proportion of women with uric acid concentrations > 5.5 mg/dL, 54.0% vs 40.3%, P < .001).

conclusionDecades after pregnancy, women who had an HPD have higher uric acid concentrations. This effect does not appear to be explained by a familial predisposition to elevated uric acid concentrations.

Indexed as

AdultBiomarkersBlack PeopleCardiovascular DiseasesCausalityComorbidityCross-Sectional StudiesFemaleHispanic or LatinoHumansHypertension, Pregnancy-InducedMiddle AgedPregnancyPrognosisRisk FactorsSurveys and QuestionnairesBiomarkersUric Acid

Identifiers

PMID26260220
PMCPMC4567408
OpenAlexW1841769217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.